We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INGR icon
1526
Ingredion
INGR
$6.58B
-15,319
Closed -$1.98M
IONS icon
1527
Ionis Pharmaceuticals
IONS
$9.4B
-173,750
Closed -$7.66M
IRDM icon
1528
Iridium Communications
IRDM
$5.29B
-70,617
Closed -$794K
IRT icon
1529
Independence Realty Trust
IRT
$4.07B
-61,948
Closed -$569K
ITRN icon
1530
Ituran Location and Control
ITRN
$1.05B
-8,445
Closed -$263K
IVZ icon
1531
Invesco
IVZ
$13.9B
-119,344
Closed -$3.82M
JAZZ icon
1532
Jazz Pharmaceuticals
JAZZ
$16.7B
-6,664
Closed -$1.01M
JILL icon
1533
J. Jill
JILL
$283M
-2,919
Closed -$54K
JKS
1534
JinkoSolar
JKS
$891M
-12,812
Closed -$234K
JLL icon
1535
Jones Lang LaSalle
JLL
$16.7B
-1,237
Closed -$216K
JRVR icon
1536
James River Group Holdings
JRVR
$217M
-7,904
Closed -$280K
KDP icon
1537
Keurig Dr Pepper
KDP
$40.8B
-19,662
Closed -$2.33M
KEX icon
1538
Kirby Corp
KEX
$6.93B
-12,920
Closed -$994K
KLIC icon
1539
Kulicke & Soffa
KLIC
$4.78B
-523,824
Closed -$13.1M
KN icon
1540
Knowles
KN
$3.34B
-153,900
Closed -$1.94M
KNSL icon
1541
Kinsale Capital Group
KNSL
$8.51B
-36,182
Closed -$1.86M
KOF icon
1542
Coca-Cola Femsa
KOF
$23.2B
-8,432
Closed -$560K
LBRDA icon
1543
Liberty Broadband Class A
LBRDA
$5.16B
-6,016
Closed -$510K
LBRDK icon
1544
Liberty Broadband Class C
LBRDK
$5.15B
-17,328
Closed -$1.49M
LBTYA icon
1545
Liberty Global Class A
LBTYA
$3.6B
-358,967
Closed -$11.2M
LBTYK icon
1546
Liberty Global Class C
LBTYK
$3.49B
-460,352
Closed -$14M
LDOS icon
1547
Leidos
LDOS
$17.3B
-225,996
Closed -$14.8M
LECO icon
1548
Lincoln Electric
LECO
$15.4B
-67,925
Closed -$6.11M
LEN.B icon
1549
Lennar Class B
LEN.B
$20.8B
-7,579
Closed -$344K
LH icon
1550
Labcorp
LH
$25.9B
-28,688
Closed -$3.99M

Similar funds

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.